ClinConnect ClinConnect Logo
Search / Trial NCT03803735

Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa

Launched by FRENCH AFRICA PEDIATRIC ONCOLOGY GROUP · Jan 14, 2019

Trial Information

Current as of October 02, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding childhood cancer in French-speaking countries in Africa. It aims to collect important information about children who come to oncology units for treatment. By gathering details on the types of cancer, how advanced they are when diagnosed, the treatments given, and the results of those treatments, the researchers hope to improve the care and planning for pediatric cancer programs in the region.

If your child is under 18 and has been diagnosed with any type of cancer, they may be eligible to participate in this study. The researchers are currently recruiting participants, so families can expect to share information about their child's condition and treatment. This data will be vital for local and national health authorities to better support and improve services for children with cancer in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Any child presenting at any one of the participating units for treatment
  • 2. Any child with any type of cancer
  • 3. Any child or adolescent less than 18 years of age.
  • Exclusion Criteria:
  • 1. No cancer found
  • 2. Age greater than 18 years -

About French Africa Pediatric Oncology Group

The French Africa Pediatric Oncology Group (FAPOG) is a collaborative network dedicated to improving outcomes for children with cancer in Africa. Comprising a multidisciplinary team of healthcare professionals, researchers, and advocates, FAPOG aims to enhance clinical practices, promote research initiatives, and foster capacity building within pediatric oncology. Through innovative clinical trials and partnerships with local institutions, FAPOG seeks to address the unique challenges faced by pediatric cancer patients in African contexts, ensuring equitable access to effective treatments and improving survival rates across the region.

Locations

Ouagadougou, Burkina Faso

Ouagadougou, Burkina Faso

Yaoundé, Cameroon

Kinshasa, Congo, The Democratic Republic Of The

Lubumbashi, Congo, The Democratic Republic Of The

Abidjan, Côte D'ivoire

Villejuif, Paris, France

Libreville, Gabon

Antananarivo, Ampefiloha, Madagascar

Bamako, Mali

Nouakchott, Mauritania

Niamey, Niger

Dakar, Senegal

Lomé, Togo

Patients applied

0 patients applied

Trial Officials

Brenda Mallon, MSc

Study Director

French Africa Pediatric Oncology Group

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials